| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Anti-IgE [EPC] | 2 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 10 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 11 | Retinoid [EPC] | 2 | 0.0000 |
| 12 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 13 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 14 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 15 | Corticosteroid [EPC] | 1 | 0.0000 |